论文部分内容阅读
肝细胞癌(hepatocellularcar cinoma,HCC)作为全球高发的恶性肿瘤之一,发病机理不详,早期症状不典型,临床缺乏有效的检测及治疗手段,预后差,死亡率高。据统计全球每年有600 000人死于肝癌,肝癌病人5年生存率小于5%[1]。研究
Hepatocellular carcinoma (HCC) is one of the most malignant tumors in the world. The pathogenesis is unknown. Early symptoms are not typical. HCC is lack of effective detection and treatment methods. The prognosis is poor and the mortality rate is high. According to statistics, 600,000 people die of liver cancer each year worldwide, and the 5-year survival rate of liver cancer patients is less than 5% [1]. the study